EURIdoc is a new interdisciplinary doctoral programme in the Upper Rhine region in the field of immunology. It includes 28 doctoral positions for young scientists from all over the world. The programme is run and coordinated by Eucor – The European Campus.
The doctoral research is carried out at the EURIdoc partner institutions:
Universität Basel, Switzerland
Albert-Ludwigs-Universität Freiburg, Germany
Karlsruher Institut für Technologie, Germany
Université de Strasbourg, France
Universitätsklinikum Freiburg, Germany
The scientific orientation of EURIdoc is based on the immunological foci that exist in Basel, Freiburg, Karlsruhe and Strasbourg. The core topics of EURIdoc are haematopoiesis and development of the immune system, innate and adaptive immunity as well as immune-related diseases. The emphasis is on both basic research and work on applications. In the long term, these may lead to new drugs, vaccines or therapies, for example for cancer, viral or autoimmune diseases. The project also focuses on the most urgent immunological problem of our time, SARS-CoV-2, and plans to develop new therapies for Covid-19.
EURIdoc has the following eligibility criteria:
1. The candidates must hold an academic degree, which allows them to embark on a doctoral programme at the recruiting universities before the recruitment date of 1 November 2021.
2. The candidates should have studied any field of the life-sciences, such as biology, biochemistry, biotechnology or molecular medicine. However, if a change in orientation seems justified, this should be explained.
3. The candidates must be, at the date of the call deadline, in the first four years (full-time equivalent research experience) after achieving a Master’s degree or equivalent and not yet have been awarded a doctoral degree.
4. The candidates have to comply with the mobility requirements of the PhD programme (MSCA-rules): not have resided or carried out their main activity (work, studies) in the country that will recruit the applicant for more than 12 months in the 3 years before the recruitment date of 1 November 2021. For refugees under the Geneva Convention, the refugee procedure (i.e. before refugee status is conferred) is not counted as a period of residence/activity in the country of the host organisation. Applicants will be asked to sign a self-declaration that she/he complies with the MSCA mobility criterion.
Beyond the university sector, the doctoral candidates will also work with four clinics and ten industrial partners. They will have the opportunity to spend research periods in leading pharmaceutical companies as well as in small and medium-sized companies.
The project strengthens the strategic thematic focus “Personalised Health – Precision Medicine” of the trinational alliance. EURIdoc is based on the existing close cooperation between the participating immunologists from Basel, Freiburg and Strasbourg. Since 2017, they have been networked as the Upper Rhine Immunology Group (URI group) and organise annual clinical workshops and scientific meetings. In addition to a Seed Money project aiming at cross-border connection among master’s programmes, EURIdoc now forms another building block of cooperation and education in immunology in the Upper Rhine region.
EURIdoc has been selected by the European Commission as an innovative international and interdisciplinary doctoral programme. Within the framework of the COFUND programme of the Marie Skłodowska-Curie Actions (Horizon 2020), EURIdoc receives funding of 3 million euros from the European Union. Together with the co-financing of the participating partner organisations, the programme has a total of 6.8 million euros at its disposal over a period of five years.
If you are interested in joining EURIdoc, please look at the projects we offer and at the Guide for Applicants.
Selection and recruitment will be done in cooperation with the well known Spemann Graduate School of Biology and Medicine, SGBM, in Freiburg.
Applications must be submitted via the application tool of SGBM. In addition, a self-declaration form has to be filled out and sent separately to the email address indicated in the form.
Application deadline is June 14, 2021.